Official Title
Applicability of Whole Genome Sequencing for Human Blood Group Genotyping and Genetic Definition of New Alleles as Exemplified on References and the Two MNSs-variants: U- and Stones(a)+
Brief Title
Whole Genome Sequencing for Blood Group Genotyping and Definition as Exemplified on U- and St(a)+.
Protocol ID
NCT02534519
Lead Sponsor
Blood Donation Service Zurich, SRC
Brief Summary
No health condition(s) are studied. Genetic background of blood groups is studied. U- and
Stones(a)+ ("Caucasian type") are used as proof-of-principle samples. Disease
associations of all blood group genes investigated are very rare, e.g. < 1 among 1'000
Swiss individuals (see table 1), and are not to be expected in the course of this study.
Genomic DNA of 2 U- samples were both provided as blinded reference material from New
York and Vienna blood centres, respectively. Both donors are lost for follow up, and
although there is no documented evidence for refusal of the respective donors to use
their material in research projects, samples still lack informed consent.
Detailed Description
All 34 human blood group systems have at least two antithetical antigens and are of
potential relevance during pregnancy and transfusion. Fortunately for every day routine
practice, immunizations to foreign antigens are rare. Still, incompatibilities may occur
in all blood group systems and will then require typing for the respective blood group
antigens.
Blood genotyping evolved as the method of choice, in cases when typing reagents are
commercially unavailable, or blood is inaccessible (foetus). In databases, most entries
of blood group genes lack representative polymorphism (e.g. number of alleles). Moreover,
many blood group antigens are insufficiently described in their intronic and
inter-genetic sequences. This is true for results of unequal crossing-overs,
gene-conversions and large insertions/deletions between highly homologous genes,
especially within the blood group systems of Rhesus, e.g. RhD/RhCE and MN/Ss,
respectively. Only Whole Genome Sequencing (WGS) allows for resolution of both problems:
it delivers the whole blood group genome of an individual, and simultaneously recognizes
new blood group alleles, or haplotypes. This request for ethical approval wants to test
this assumption.
The antigenic determinants U- and Stones(a)+ of the blood group system MNSs still lack
full genetic description and will serve as challenging examples for the description of
new alleles (haplotypes) caused by large ins/del mutations of the two highly homologous
genes GYPA and B. Genomic DNA of 2 U- samples were both provided as blinded reference
material from New York and Vienna blood centres, respectively. Both donors are lost for
follow up, and although there is no documented evidence for refusal of the respective
donors to use their material in research projects, samples still lack informed consent.
Additional reference samples (n max=4), and samples with suspected Stones(a)+ (n max=4)
will be recruited from Zurich blood donors with informed consent, only.
Enrollment Count
8 participants
Eligibility Criteria
Inclusion Criteria:
- Existing biomaterial (gDNA), or
- Existing health related data for blood group U- (n max=2) and eligible for (venous)
blood sampling of 20 mL, or
- Existing blood group pheno- and genotyping data indicating St(a)+ and eligible for
(venous) blood sampling of 20 mL (n max=2), or
- Adequate blood group profile serving as reference (n max =4 & n max =4'000) and
eligible for (venous) blood sampling of 20 mL.
Exclusion Criteria:
- Ineligible for venous blood sampling of approx. 20 mL.
Filters
Genetic Blood Group (bg) Polymorphism in U Negativity and St(a) of MNSs
UNKNOWN
CHILD
ADULT
OLDER_ADULT